Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response (2015)
- Authors:
- USP affiliated authors: ANDRADE, JURANDYR MOREIRA DE - FMRP ; TIEZZI, DANIEL GUIMARÃES - FMRP
- Unidade: FMRP
- Subjects: COLO UTERINO; QUIMIOTERAPIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Abstracts
- Conference titles: International Meeting of the European Society of Gynaecological Oncology
-
ABNT
SOUZA, C. B. de et al. Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response. 2015, Anais.. Nice: ESGO, 2015. . Acesso em: 28 dez. 2025. -
APA
Souza, C. B. de, Andrade, J. M. de, Schiavon, V. F., Clagnan, W. S., & Tiezzi, D. G. (2015). Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response. In Abstracts. Nice: ESGO. -
NLM
Souza CB de, Andrade JM de, Schiavon VF, Clagnan WS, Tiezzi DG. Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response. Abstracts. 2015 ;[citado 2025 dez. 28 ] -
Vancouver
Souza CB de, Andrade JM de, Schiavon VF, Clagnan WS, Tiezzi DG. Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response. Abstracts. 2015 ;[citado 2025 dez. 28 ] - Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
- Volume of breast tissue excised during breast-conserving surgery in patients undergoing preoperative systemic therapy
- Expression of hypoxia-inducible factor 1-'alfa' and vascular endothelial growth factor-C in locally advanced breast cancer patients
- Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression
- Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab
- IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment
- Impacto prognóstico da recorrência local em pacientes com câncer inicial de mama submetidas a tratamento conservador
- Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer
- HIF-1'alfa' and locally advanced breast cancer [Carta]
- Impact of surgical staging in locally advanced cervical cancer and subsequent chemotherapy
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
